Literature DB >> 20970940

Triphasic contrast injection improves evaluation of dual energy lung perfusion in pulmonary CT angiography.

J Matthias Kerl1, Ralf W Bauer, Matthias Renker, Eva Weber, Philipp Weisser, Huedayi Korkusuz, Boris Schell, Maya Christina Larson, Wolfgang Kromen, Volkmar Jacobi, Thomas J Vogl.   

Abstract

PURPOSE: Lung perfusion analysis at dual energy CT (DECT) is sensitive to beam hardening artifacts from dense contrast material (CM). We compared two scan and four CM injection protocols in terms of severity of artifacts and attenuation levels in the thoracic vessels. METHODS AND MATERIALS: Data of 120 patients who had undergone dual source dual energy CT pulmonary angiography for suspected acute pulmonary embolism were evaluated. Group 1 (n=30) was scanned in craniocaudal direction using 64×0.6 mm collimation; groups 2-4 (n=30 each) were scanned in caudocranial direction using 14×1.2 mm collimation. In groups 1-3 biphasic injection protocols with different amounts of CM and NaCl were investigated. In group 4 a split-bolus protocol with an initial CM bolus of 50 ml followed by 30 ml of a 70%:30% NaCl/CM mixture and a 50 ml NaCl chaser bolus was used. CT density values in the subclavian vein (SV), superior vena cava (SVC), pulmonary artery tree (PA), and the descending aorta (DA) were measured. Artifacts arising from the SV and SVC on DE pulmonary iodine distribution map were rated on a scale from 1 to 5 (1=fully diagnostic; 5=non-diagnostic) by two blinded readers.
RESULTS: In protocol 4 mean attenuation in the SV (645±158 HU) and SVC (389±114 HU) were significantly lower compared to groups 1-3 (p<0.002). Artifacts in group 4 (1.1±0.4 and 1.5±0.7 for the SV and SVC, respectively) were rated significantly less severe compared to group 1 (3.2±1.0 and 3.0±1.1), 2 (2.6±1.1 and 2.3±1.0) and 3 (1.9±0.9 and 1.9±0.7) (p<0.01 for all), whereas no significant difference was found between groups 1 and 2 for the subclavian vein (p=0.07). Attenuation in the PA was also significantly lower in group 4 (282±116 HU) compared to group 1 (397±137 HU), group 2 (376±115 HU) and group 3 (311±104 HU), but still on a diagnostic level.
CONCLUSION: Split-bolus injection provides sufficient attenuation for pulmonary DECT angiography while beam hardening artifacts arising from high density contrast material in the thoracic vessels can be reduced significantly.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970940     DOI: 10.1016/j.ejrad.2010.09.030

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

Review 1.  Dual-energy lung perfusion and ventilation CT in children.

Authors:  Hyun Woo Goo
Journal:  Pediatr Radiol       Date:  2013-02-16

Review 2.  Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Ho Yun Lee; Sachiko Miura; Takeshi Yoshikawa; Kazuro Sugimura
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

3.  Split-Bolus Single-Pass Multidetector-Row CT Protocol for Diagnosis of Acute Pulmonary Embolism.

Authors:  Michele Scialpi; Alberto Rebonato; Lucio Cagini; Luca Brunese; Irene Piscioli; Luisa Pierotti; Lucio Bellantonio; Alfredo D'Andrea; Antonio Rotondo
Journal:  Iran J Radiol       Date:  2016-01-14       Impact factor: 0.212

4.  Imaging protocols for CT chest: A recommendation.

Authors:  Ashu Seith Bhalla; Abanti Das; Priyanka Naranje; Aparna Irodi; Vimal Raj; Ankur Goyal
Journal:  Indian J Radiol Imaging       Date:  2019-10-30

5.  Dual-energy CT angiography in suspected pulmonary embolism: influence of injection protocols on image quality and perfused blood volume.

Authors:  Aleksander Kosmala; Philipp Gruschwitz; Simon Veldhoen; Andreas Max Weng; Bernhard Krauss; Thorsten Alexander Bley; Bernhard Petritsch
Journal:  Int J Cardiovasc Imaging       Date:  2020-06-06       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.